BlackRock Institutional Trust’s bluebird bio BLUE Stock Holding History

BlackRock Institutional Trust’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$62M	Buy	77,625 +5,387	+7%	+$4.28M	0.01%	1200
2016 Q3	$63.4M	Buy	72,238 +2,529	+4%	+$1.83M	0.01%	1133
2016 Q2	$39.1M	Buy	69,709 +2,485	+4%	+$1.41M	0.01%	1394
2016 Q1	$37M	Sell	67,224 -659	-1%	-$405K	0.01%	1416
2015 Q4	$56.5M	Buy	67,883 +1,257	+2%	+$1.26M	0.01%	1168
2015 Q3	$73.8M	Buy	66,626 +9,107	+16%	+$16.6M	0.01%	1009
2015 Q2	$125M	Buy	57,519 +4,295	+8%	+$8.75M	0.02%	767
2015 Q1	$83.3M	Buy	53,224 +11,605	+28%	+$15.3M	0.01%	1030
2014 Q4	$49.4M	Sell	41,619 -3,578	-8%	-$2.39M	0.01%	1306
2014 Q3	$21M	Buy	45,197 +29,211	+183%	+$13.5M	﹤0.01%	1834
2014 Q2	$7.99M	Buy	15,986 +9,470	+145%	+$3.04M	﹤0.01%	2557
2014 Q1	$1.92M	Buy	6,516 +1,206	+23%	+$365K	﹤0.01%	3178
2013 Q4	$1.44M	Buy	5,310 +386	+8%	+$108K	﹤0.01%	3277
2013 Q3	$1.72M	Buy	+4,924	New	+$1.83M	﹤0.01%	3200

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BlackRock Institutional Trust's BLUE Position: Q4 2016 in Review

BlackRock Institutional Trust increased its bluebird bio (BLUE) stake by 7.5% in Q4 2016, buying an estimated $4.28M and bringing the position to 77,625 shares worth $62M. The position accounts for 0.01% of the portfolio, ranked #1200.

BlackRock Institutional Trust first reported a position in BLUE in Q3 2013 and has held it in 14 quarters since. The position peaked at $125M in Q2 2015. 199 funds tracked by Wall St. Rank hold BLUE as of Q4 2016.

BlackRock Institutional Trust held 77,625 shares of bluebird bio worth $62M as of Q4 2016.
BlackRock Institutional Trust bought 5,387 bluebird bio shares in Q4 2016, an estimated $4.28M.
bluebird bio made up 0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1200 holding.
BlackRock Institutional Trust first reported a position in bluebird bio in Q3 2013 and has held it in 14 quarters since.
BlackRock Institutional Trust's bluebird bio position peaked at $125M in Q2 2015.
199 funds tracked by Wall St. Rank held bluebird bio as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.